VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $363,247 | +44.1% | 12,674 | +21.3% | 0.01% | 0.0% |
| Q3 2022 | $252,000 | -11.9% | 10,445 | 0.0% | 0.01% | -7.7% |
| Q2 2022 | $286,000 | -28.7% | 10,445 | 0.0% | 0.01% | -23.5% |
| Q1 2022 | $401,000 | +1.8% | 10,445 | -15.1% | 0.02% | +13.3% |
| Q4 2021 | $394,000 | -87.5% | 12,296 | -88.5% | 0.02% | -90.1% |
| Q3 2021 | $3,151,000 | -16.0% | 106,909 | -3.2% | 0.15% | -23.6% |
| Q2 2021 | $3,752,000 | +7.0% | 110,429 | +2.3% | 0.20% | -0.5% |
| Q1 2021 | $3,508,000 | -22.1% | 107,930 | -13.7% | 0.20% | -27.5% |
| Q4 2020 | $4,505,000 | -1.2% | 125,063 | +7.4% | 0.28% | -13.5% |
| Q3 2020 | $4,562,000 | +12.6% | 116,492 | +5.5% | 0.32% | -4.5% |
| Q2 2020 | $4,052,000 | +1246.2% | 110,468 | +745.7% | 0.33% | +943.8% |
| Q1 2020 | $301,000 | -21.8% | 13,062 | -0.8% | 0.03% | +18.5% |
| Q4 2019 | $385,000 | +9.4% | 13,162 | 0.0% | 0.03% | +8.0% |
| Q3 2019 | $352,000 | – | 13,162 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |